Cited by 34Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model OrganismsSirtuins and Resveratrol in Medicine

Context‐dependent roles of cellular senescence in normal, aged, and disease states

Moiseeva, Victoria, Cisneros, Andrés, Cobos, Aina Calls, Tarrega, Aida Beà, Oñate, Claudia Santos, Perdiguero, Eusebio, Serrano, Antonio L., Muñoz‐Cánoves, Pura·2023·The FEBS Journal

Abstract

Cellular senescence is a state of irreversible cell cycle arrest that often emerges after tissue damage and in age‐related diseases. Through the production of a multicomponent secretory phenotype (SASP), senescent cells can impact the regeneration and function of tissues. However, the effects of senescent cells and their SASP are very heterogeneous and depend on the tissue environment and type as well as the duration of injury, the degree of persistence of senescent cells and the organism's age. While the transient presence of senescent cells is widely believed to be beneficial, recent data suggest that it is detrimental for tissue regeneration after acute damage. Furthermore, although senescent cell persistence is typically associated with the progression of age‐related chronic degenerative diseases, it now appears to be also necessary for correct tissue function in the elderly. Here, we discuss what is currently known about the roles of senescent cells and their SASP in tissue regeneration in ageing and age‐related diseases, highlighting their (negative and/or positive) contributions. We provide insight for future research, including the possibility of senolytic‐based therapies and cellular reprogramming, with aims ranging from enhancing tissue repair to extending a healthy lifespan.

Integrity signals

Registry

Crossref · 10.1111/febs.16573

Cites

246 of 246 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • These findings challenge the prevalent view that senescent cells are beneficial when transiently present after acute injury, particularly in young tissue.

    “These findings challenge the prevalent view that senescent cells are beneficial when transiently present after acute injury, particularly in young tissue (reviewed in refs. 28,29).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Moiseeva, V., Cisneros, A., Cobos, A. C., Tarrega, A. B., Oñate, C. S., Perdiguero, E., Serrano, A. L., & Muñoz‐Cánoves, P.
Affiliations
  • Universitat Pompeu Fabra (ES)
  • Department of Experimental and Health Sciences Pompeu Fabra University (UPF), CIBER on Neurodegenerative Diseases (CIBERNED) Barcelona Spain
  • Institució Catalana de Recerca i Estudis Avançats (ES)
Corresponding author
Muñoz‐Cánoves, Pura
Venue
The FEBS Journal
Publisher
Wiley
Published
2022-08-02
Volume
290
Issue
5
Pages
1161-1185
ISSN
  • 1742-464X (ISSN-L)
  • 1742-4658
OpenAlex
W4285006159
Cited by
34
References
246
Citations by year
2026: 11 · 2025: 12 · 2024: 6 · 2023: 4 · 2022: 1
FWCI
0.79
Type
journal article
Language
en
Open access
closed
Locations
  • FEBS Journal (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Muscular Dystrophy Association
  • French Muscular Dystrophy Association
  • H2020 European Research Council (2016‐AdG‐741966)
Topics
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
Keywords
cellular senescence, senescence-associated secretory phenotype, tissue regeneration, aging, age-related diseases, senolytic therapy, cellular reprogramming, healthspan, tissue damage, chronic degenerative diseases, context sensitivity
MeSH terms
Biological Transport, Longevity, Phenotype, Cellular Senescence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review